Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Toumaz Ltd Announces Results of Pilot Study for SensiumVitals Disposable Wireless Vital Signs Monitoring Solution


Thursday, 25 Apr 2013 02:01am EDT 

Toumaz Ltd announced the results of the pilot study for its SensiumVitals disposable wireless vital signs monitoring solution. The study detected all patients who experienced deterioration in their condition between routine ward observation rounds, preventing more serious clinical problems and saving an average of USD 9,004 per patient, per stay. The pilot study at Saint John's Health Center, Santa Monica, USA demonstrated that the use of SensiumVitals on patients in the general wards of the hospital facilitated early intervention and avoided the escalation of their conditions and prevented costly admissions to intensive care or high dependency units. It also contributed significantly to shorter hospital stays. SensiumVitals is an ultra-light weight, wireless, wearable, FDA-cleared medical device. It enables caregivers to rapidly detect changes in temperature, heart and respiration rates. 

Company Quote

4.625
-0.125 -2.63%
10:42am EST